US approves HIV home test kit


An HIV home test kit has been approved for marketing in the US. The ‘OraQuick’ kit from US diagnostics firm OraSure, is already in use by clinics, but until now the company has not been allowed to market it for home use.

Users collect an oral sample by swabbing their gums and putting the swab into a buffer solution. The kit then provides a result in 20–40 minutes.

The Food and Drug Administration says that the test should not be considered conclusive. It gets the answer right 92% of the time when the user is infected and 99.98% when they aren't. Despite this shortcoming, the FDA adds: ‘The test has the potential to identify large numbers of previously undiagnosed HIV infections, especially if used by those unlikely to use standard screening methods.’

OraSure is planning to launch the home test version of the kit in October.


Related Content

Chemistry World podcast - January 2014

15 January 2014 Podcast | Monthly

news image

This month, we examine the controversy surrounding the Turin shroud and explore the history of crystallography

First HIV drug approved as prevention

17 July 2012 Business

news image

Truvada tablets can reduce the risk of infection for an HIV-negative person

Most Read

Linguistic statistics enable synthetic prophetics

17 July 2014 Research

news image

A metric more commonly used by search engines to analyse language can now power organic chemistry retrosyntheses

Coffee cup confusion

20 July 2014 Research

news image

Scientists call for better labelling after research highlights inconsistencies in the chemical composition of a cup of coffee

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Coffee cup confusion

20 July 2014 Research

news image

Scientists call for better labelling after research highlights inconsistencies in the chemical composition of a cup of coffee